eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Phase III clinical trial comparing trastuzumab given concurrently with radiation therapy and radiation therapy alone for women with HER2-positive ductal carcinoma in situ resected by lumpectomy

eagle-i ID


Resource Type

  1. Clinical trial


  1. ClinicalTrials.gov url
  2. Intervention
  3. Intervention
  4. Additional Topic(s)
  5. Resource Description
    This randomized phase III trial is studying radiation therapy to see how well it works compared with or without trastuzumab in treating women with ductal carcinoma in situ who have undergone lumpectomy.
  6. Contact
    Berenberg, Jeffrey
  7. PI
    Berenberg, Jeffrey
  8. Topic
    invasive ductal carcinoma
  9. Study Population
    Women aged 18 years and older with histologically confirmed ductal carcinoma in situ (DCIS) who have have undergone resection by lumpectomy with no more than 120 days since the last surgery for excision of DCIS.
  10. Website(s)
  11. Funded by
    National Surgical Adjuvant Breast and Bowel Project
  12. Phase
    Phase 3 clinical trial
  13. Performed by
    Clinical Protocol & Data Management Shared Resource
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016